Natixis Boosts Stake in GE HealthCare Technologies Inc. $GEHC

Natixis grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 181.1% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 76,990 shares of the company’s stock after buying an additional 49,602 shares during the period. Natixis’ holdings in GE HealthCare Technologies were worth $5,703,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Lineweaver Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies in the second quarter worth $592,000. Guggenheim Capital LLC boosted its position in GE HealthCare Technologies by 22.3% during the 2nd quarter. Guggenheim Capital LLC now owns 131,985 shares of the company’s stock worth $9,776,000 after purchasing an additional 24,087 shares during the period. Exome Asset Management LLC acquired a new stake in GE HealthCare Technologies in the 1st quarter valued at $2,050,000. Nvwm LLC increased its holdings in GE HealthCare Technologies by 5,483.1% in the 2nd quarter. Nvwm LLC now owns 14,237 shares of the company’s stock valued at $1,055,000 after purchasing an additional 13,982 shares in the last quarter. Finally, Dodge & Cox raised its position in GE HealthCare Technologies by 42.1% in the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after purchasing an additional 6,982,441 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 0.1%

Shares of NASDAQ:GEHC opened at $83.03 on Wednesday. The firm has a market cap of $37.82 billion, a PE ratio of 17.15, a price-to-earnings-growth ratio of 3.47 and a beta of 1.10. The company has a fifty day simple moving average of $76.31 and a 200 day simple moving average of $74.72. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm’s revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.89%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on GEHC shares. Zacks Research downgraded GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Stifel Nicolaus set a $90.00 price target on GE HealthCare Technologies in a research report on Friday, November 21st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 1st. Evercore ISI lifted their price objective on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Finally, Barclays assumed coverage on shares of GE HealthCare Technologies in a research report on Monday, October 13th. They set an “equal weight” rating and a $86.00 target price on the stock. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average price target of $86.45.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.